Q3 2024 |
25 |
$3.98B |
+$553M |
-$91M |
+$462M |
AVGO, PEG, ABBV, ORI, UL
|
13F-HR |
10/24/2024, 12:32 PM |
Q2 2024 |
26 |
$3.4B |
+$153M |
-$103M |
+$50M |
AVGO, PEG, ABBV, COP, LAMR
|
13F-HR |
8/13/2024, 05:15 PM |
Q1 2024 |
25 |
$3.39B |
+$209M |
-$240M |
-$31.3M |
AVGO, ABBV, COP, LAMR, ARES
|
13F-HR |
5/15/2024, 11:40 AM |
Q4 2023 |
27 |
$3.18B |
+$88.3M |
-$74.4M |
+$13.9M |
AVGO, ARES, COP, ABBV, LAMR
|
13F-HR |
1/9/2024, 02:48 PM |
Q3 2023 |
26 |
$2.91B |
+$78M |
-$54.1M |
+$23.9M |
AVGO, COP, ABBV, ARES, EPD
|
13F-HR |
10/4/2023, 02:49 PM |
Q2 2023 |
26 |
$2.98B |
+$147M |
-$120M |
+$27.7M |
AVGO, ARES, PG, COP, LAMR
|
13F-HR |
7/14/2023, 09:51 AM |
Q1 2023 |
25 |
$2.87B |
+$212M |
-$247M |
-$34.5M |
AVGO, ABBV, PG, LAMR, GPC
|
13F-HR |
4/13/2023, 08:12 AM |
Q4 2022 |
27 |
$2.82B |
+$120M |
-$91.4M |
+$28.7M |
GPC, ABBV, AVGO, COP, PG
|
13F-HR |
1/20/2023, 03:35 PM |
Q3 2022 |
28 |
$2.5B |
+$259M |
-$158M |
+$101M |
GPC, COP, ABBV, EPD, KDP
|
13F-HR |
10/13/2022, 11:55 AM |
Q2 2022 |
29 |
$2.49B |
+$250M |
-$257M |
-$7.7M |
ABBV, GPC, JNJ, COP, EPD
|
13F-HR |
7/12/2022, 04:08 PM |
Q1 2022 |
26 |
$2.84B |
+$166M |
-$127M |
+$39.5M |
ABBV, AVGO, COP, ORI, PEG
|
13F-HR |
4/19/2022, 03:34 PM |
Q4 2021 |
28 |
$2.82B |
+$295M |
-$249M |
+$46M |
AVGO, ABBV, KEY, GPC, ORI
|
13F-HR |
1/25/2022, 01:23 PM |
Q3 2021 |
28 |
$2.51B |
+$37.1M |
-$20.8M |
+$16.3M |
KEY, ORI, AVGO, LAMR, IPG
|
13F-HR |
10/14/2021, 01:28 PM |
Q2 2021 |
28 |
$2.54B |
+$185M |
-$211M |
-$25.6M |
ORI, GPC, KEY, ABBV, LAMR
|
13F-HR |
7/14/2021, 04:06 PM |
Q1 2021 |
29 |
$2.44B |
+$288M |
-$254M |
+$33.7M |
ORI, GPC, KEY, STLD, AVGO
|
13F-HR |
4/14/2021, 06:09 PM |
Q4 2020 |
29 |
$2.17B |
+$267M |
-$252M |
+$15.1M |
KEY, AVGO, ABBV, GPC, ORI
|
13F-HR |
1/26/2021, 12:11 PM |
Q3 2020 |
28 |
$1.89B |
+$343M |
-$402M |
-$58.9M |
VZ, KEY, AVGO, QCOM, PEG
|
13F-HR |
10/13/2020, 12:43 PM |
Q2 2020 |
36 |
$1.87B |
+$320M |
-$377M |
-$56.9M |
CVX, T, VZ, JNJ, ABBV
|
13F-HR |
7/15/2020, 08:59 AM |
Q1 2020 |
42 |
$1.67B |
+$550M |
-$825M |
-$275M |
VZ, T, PFE, SNY, ABBV
|
13F-HR |
5/11/2020, 12:23 PM |
Q4 2019 |
41 |
$2.4B |
+$135M |
-$40.1M |
+$95.3M |
T, VZ, TGT, BCE, EPD
|
13F-HR |
1/17/2020, 03:37 PM |
Q3 2019 |
37 |
$2.22B |
+$103M |
-$276M |
-$173M |
T, VZ, TGT, BCE, EPD
|
13F-HR |
10/16/2019, 11:03 AM |
Q2 2019 |
39 |
$2.33B |
+$249M |
-$224M |
+$24.4M |
T, VZ, PFE, EPD, BCE
|
13F-HR |
7/22/2019, 04:39 PM |
Q1 2019 |
38 |
$2.24B |
+$48.6M |
-$149M |
-$101M |
VZ, T, EPD, TGT, PFE
|
13F-HR |
4/12/2019, 04:23 PM |
Q4 2018 |
47 |
$2.15B |
+$393M |
-$560M |
-$168M |
VZ, PFE, QCOM, T, BCE
|
13F-HR |
1/18/2019, 04:14 PM |
Q3 2018 |
42 |
$2.55B |
+$121M |
-$123M |
-$1.87M |
PFE, CSCO, T, QCOM, EPD
|
13F-HR |
10/15/2018, 04:19 PM |
Q2 2018 |
39 |
$2.46B |
+$408M |
-$551M |
-$143M |
T, STAY, EPD, PFE, CSCO
|
13F-HR |
7/12/2018, 02:09 PM |
Q1 2018 |
42 |
$2.59B |
+$409M |
-$359M |
+$49.4M |
RDSB, INTC, T, CSCO, STAY
|
Restatement |
4/18/2018, 05:09 PM |
Q4 2017 |
40 |
$2.6B |
+$255M |
-$245M |
+$9.83M |
CSCO, RDSB, T, GM, PFE
|
13F-HR |
1/31/2018, 04:06 PM |
Q3 2017 |
34 |
$2.47B |
+$159M |
-$174M |
-$15.1M |
RDSB, T, CSCO, GM, STAY
|
13F-HR |
10/23/2017, 03:55 PM |
Q2 2017 |
36 |
$2.4B |
+$360M |
-$326M |
+$33.4M |
STAY, EPD, PFE, GM, T
|
13F-HR |
7/27/2017, 04:54 PM |
Q1 2017 |
40 |
$2.37B |
+$449M |
-$379M |
+$69.5M |
PFE, RDSB, GM, ETN, CSCO
|
13F-HR |
4/26/2017, 11:47 AM |
Q4 2016 |
43 |
$2.24B |
+$157M |
-$142M |
+$15.2M |
GM, RHP, T, KSS, HPT
|
13F-HR |
1/27/2017, 01:18 PM |
Q3 2016 |
41 |
$2.16B |
+$246M |
-$212M |
+$34.3M |
GM, CSCO, WY, ABBNY, HPT
|
13F-HR |
10/20/2016, 04:08 PM |
Q2 2016 |
40 |
$2.06B |
+$261M |
-$199M |
+$61.5M |
T, QCOM, RGC, AEO, GM
|
13F-HR |
7/27/2016, 12:16 PM |
Q1 2016 |
38 |
$1.98B |
+$239M |
-$195M |
+$44.2M |
T, ETN, BCE, PEG, RGC
|
13F-HR |
5/2/2016, 10:33 AM |
Q4 2015 |
39 |
$1.85B |
+$227M |
-$258M |
-$31M |
T, DOW, LAMR, VOD, GM
|
13F-HR |
1/22/2016, 01:06 PM |
Q3 2015 |
41 |
$1.81B |
+$242M |
-$214M |
+$28.7M |
T, BCE, VOD, DOW, LAMR
|
13F-HR |
10/22/2015, 02:26 PM |
Q2 2015 |
41 |
$1.98B |
+$177M |
-$40.8M |
+$136M |
T, DOW, VOD, ABBV, BCE
|
13F-HR |
7/16/2015, 01:38 PM |
Q1 2015 |
40 |
$1.9B |
+$278M |
-$211M |
+$66.2M |
DOW, BCE, T, PSO, ETN
|
13F-HR |
4/30/2015, 06:38 AM |
Q4 2014 |
43 |
$1.79B |
+$344M |
-$297M |
+$47.8M |
RHP, T, DOW, VET, SON
|
13F-HR |
1/27/2015, 11:19 AM |
Q3 2014 |
45 |
$1.67B |
+$184M |
-$219M |
-$35.6M |
T, RHP, PEG, INTC, GSK
|
13F-HR |
10/31/2014, 07:59 AM |
Q2 2014 |
45 |
$1.78B |
+$272M |
-$141M |
+$131M |
T, BTE, RHP, INTC, PEG
|
13F-HR |
8/13/2014, 08:56 AM |
Q1 2014 |
41 |
$1.56B |
+$214M |
-$170M |
+$44M |
T, BTE, PEG, RHP, COP
|
13F-HR |
5/5/2014, 01:32 PM |
Q4 2013 |
42 |
$1.47B |
$0 |
$0 |
|
DOW, RHP, MRK, INTC, ABBV
|
13F-HR |
1/27/2014, 11:53 AM |